Boulder Diagnostics.

It avoids the notoriously low accuracy of usual serology based tests. ‘We are thrilled to work with the inner Medicine Division of Radboud University Nijmegen Medical Center to provide this transformative and dependable Lyme disease check to the market soon’, says Wolfgang Pieken, CEO of Boulder Diagnostics Inc. ‘The collaboration with Boulder Diagnostics we can extend the advantage of our innovative diagnostic technology beyond our organization’, remarks Leo Joosten, Associate Professor of Experimental Medication at Radboud University Nijmegen Medical Center. ‘This assay keeps the potential to considerably decrease the frequent misdiagnosis of persistent borrelia infection’, provides Mihai Netea, Professor of Experimental Medicine..2013 GUIDANCE The 2013 minimal non-GAAP EPS guidance of $1.95 excludes any potential influence of U.S. The guidance further assumes strong underlying revenue trends for several key products, additional and continued productivity savings, significant contributions from pipeline products that are anticipated to receive regulatory acceptance, and regulatory authorization of new indications for several marketed products currently, and exclusivity for ABILIFY through the term of the current contract with Otsuka Pharmaceutical Co., Ltd.

Other entries from category "gynecology":

Tag Cloud